GLYCOMIMETICS, INC.

Company

CRESCENT BIOPHARMA, INC.

Filed

January 23, 2014

Accession Number

0001072613-14-000010

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →